Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

(19)F MRI for quantitative in vivo cell tracking.

Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJ.

Trends Biotechnol. 2010 Jul;28(7):363-70. doi: 10.1016/j.tibtech.2010.04.002. Epub 2010 Apr 26. Review.

2.

Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, de Vries IJ, Ahrens ET, Mailliard RB.

Cytotherapy. 2010 Apr;12(2):238-50. doi: 10.3109/14653240903446902.

3.

In vivo cytometry of antigen-specific t cells using 19F MRI.

Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET.

Magn Reson Med. 2009 Sep;62(3):747-53. doi: 10.1002/mrm.22063.

4.

Magnetic resonance imaging-guided adoptive cellular immunotherapy of central nervous system tumors with a T1 contrast agent.

Sengar RS, Spokauskiene L, Steed DP, Griffin P, Arbujas N, Chambers WH, Wiener EC.

Magn Reson Med. 2009 Sep;62(3):599-606. doi: 10.1002/mrm.22030.

5.

In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.

Schuurhuis DH, Verdijk P, Schreibelt G, Aarntzen EH, Scharenborg N, de Boer A, van de Rakt MW, Kerkhoff M, Gerritsen MJ, Eijckeler F, Bonenkamp JJ, Blokx W, van Krieken JH, Boerman OC, Oyen WJ, Punt CJ, Figdor CG, Adema GJ, de Vries IJ.

Cancer Res. 2009 Apr 1;69(7):2927-34. doi: 10.1158/0008-5472.CAN-08-3920. Epub 2009 Mar 24.

6.

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.

Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM, Strijk S, Eijckeler F, Bonenkamp JJ, Jacobs JF, Blokx W, Vankrieken JH, Joosten I, Boerman OC, Oyen WJ, Adema G, Punt CJ, Figdor CG, de Vries IJ.

Clin Cancer Res. 2009 Apr 1;15(7):2531-40. doi: 10.1158/1078-0432.CCR-08-2729. Epub 2009 Mar 24.

7.

In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles.

Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW.

Magn Reson Med. 2008 Dec;60(6):1506-11. doi: 10.1002/mrm.21783.

8.

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.

Schuurhuis DH, Lesterhuis WJ, Kramer M, Looman MG, van Hout-Kuijer M, Schreibelt G, Boullart AC, Aarntzen EH, Benitez-Ribas D, Figdor CG, Punt CJ, de Vries IJ, Adema GJ.

Cancer Immunol Immunother. 2009 Jul;58(7):1109-15. doi: 10.1007/s00262-008-0626-y. Epub 2008 Nov 19.

PMID:
19018531
9.

Detection and quantification of magnetically labeled cells by cellular MRI.

Liu W, Frank JA.

Eur J Radiol. 2009 May;70(2):258-64. doi: 10.1016/j.ejrad.2008.09.021. Epub 2008 Nov 7. Review.

10.

Stem cell based therapy for skeletal muscle diseases.

Bhagavati S.

Curr Stem Cell Res Ther. 2008 Sep;3(3):219-28. Review.

PMID:
18782004
11.

Adult stem cell transplantation in stroke: its limitations and prospects.

Roh JK, Jung KH, Chu K.

Curr Stem Cell Res Ther. 2008 Sep;3(3):185-96. Review.

PMID:
18782001
12.

Stem cell implantation for myocardial disorders.

Yamahara K, Nagaya N.

Curr Drug Deliv. 2008 Jul;5(3):224-9. Review.

PMID:
18673267
13.

Dendritic cell vaccination and immune monitoring.

Aarntzen EH, Figdor CG, Adema GJ, Punt CJ, de Vries IJ.

Cancer Immunol Immunother. 2008 Oct;57(10):1559-68. doi: 10.1007/s00262-008-0553-y. Epub 2008 Jul 10. Review.

14.

Maximizing dendritic cell migration in cancer immunotherapy.

Verdijk P, Aarntzen EH, Punt CJ, de Vries IJ, Figdor CG.

Expert Opin Biol Ther. 2008 Jul;8(7):865-74. doi: 10.1517/14712598.8.7.865 . Review.

PMID:
18549318
15.

Noninvasive imaging of cell-mediated therapy for treatment of cancer.

Akins EJ, Dubey P.

J Nucl Med. 2008 Jun;49 Suppl 2:180S-95S. doi: 10.2967/jnumed.107.045971.

16.

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.

Boullart AC, Aarntzen EH, Verdijk P, Jacobs JF, Schuurhuis DH, Benitez-Ribas D, Schreibelt G, van de Rakt MW, Scharenborg NM, de Boer A, Kramer M, Figdor CG, Punt CJ, Adema GJ, de Vries IJ.

Cancer Immunol Immunother. 2008 Nov;57(11):1589-97. doi: 10.1007/s00262-008-0489-2. Epub 2008 Mar 6.

17.

Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection.

Janjic JM, Srinivas M, Kadayakkara DK, Ahrens ET.

J Am Chem Soc. 2008 Mar 5;130(9):2832-41. doi: 10.1021/ja077388j. Epub 2008 Feb 12.

PMID:
18266363
18.

Cell number quantification of USPIO-labeled stem cells by MRI: an in vitro study.

Cheung JS, Chow AM, Hui ES, Yang J, Tse HF, Wu EX.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:476-9.

PMID:
17945980
19.

Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model.

Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET.

Magn Reson Med. 2007 Oct;58(4):725-34.

20.

Supplemental Content

Support Center